Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Budesonide MMX Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis

NCT05341401 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05341401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05341401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Budesonide MMX Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
Lead sponsor
Assiut University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2022
Completion date
June 30, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis chronic